Nanobiotechnology and Nanomedicine Companies
Showing results 41 - 50 of 83 of companies in USA:
Develops targeted molecular imaging agents and therapeutics designed to detect and treat cancer and cardiovascular disease.
Develops and manufactures acoustic droplet ejection (ADE) systems, a fully automated, non-contact, nozzle-free technology to dispense nanoliters of liquids.
Develops and markets biological detection systems based on luminescent lanthanide complexes, which provide a unique combination of sensitivity, reliability, flexibility and high throughput.
The company utilizes its proprietary nanotechnology platform to transform existing and experimental anti-cancer agents into new, patentable drugs with superior pharmaceutical properties.
MicroConstants is a GLP-compliant Contract Research Organization (CRO) dedicated to providing premier quality bioanalytical, drug metabolism, pharmacokinetic, formulation and immunoassay support services to pharmaceutical and biotech companies worldwide.
The MicroTransponder, Inc. technology portfolio consists of a wireless micro-system that can interface with peripheral nerves and a host of biochemical micro/nano- sensors.
Develops nanoparticle based in vivo delivery applications.
NABsys is developing its proprietary Hybridization-Assisted Nanopore Sequencing (HANS) platform. This platform combines bleeding edge technology in physics, biochemistry, and computer science to sequence DNA in a way that is projected to be orders of magnitude cheaper and faster than any technology available today.
This start-up is focussed on tumor-specific nanoparticle platforms to largely improve delivery efficiency, treatment efficacy and product safety.
Develops nanobiotechnology platforms that address global healthcare needs.